Evolution of the Endonasal Microbiota in Patients With Chronic

Status Completed

Clinical Trial Summary

Chronic rhinosinusitis (CRS) is defined according to the French society of otorhinolaryngology as chronic non-mechanical damage to the nasal structures, excluding infectious damage to the sinus structures. The duration of the chronic impairment must be at least 12 consecutive weeks. It causes many symptoms such as rhinorrhea, nasal blockage and anosmia. It is a poorly understood pathology that affects a large part of the population. Its prevalence has increased significantly over the past 30 years. It affects about 11% of the population in Europe. It has become one of ten high-cost medical conditions for employers. Initially, it was accepted that CRS was due to chronic nasal infection. It is very debilitating for patients leading to a major consultation with practitioners (general practitioners and ENT specialists). Many treatments are used such as nose washes, nasal or oral corticosteroids, antibiotic therapy or even surgical management is possible. Thèses treatments allow an improvement in the symptomatology but no treatment allows a stable result over time, making long-term treatments essential. Today, it is recognized that CRS has a multifactorial etiology including inflammatory processes, hyperresponsiveness of the nasal mucosa and abnormalities in immune phenomena. The endonasal microbiota plays a role in these processes. Germs like Staphylococcus aureus and Pseudomonas aeruginosa were identified as pathogens in CRS in the first studies with bacterial cultures. Thanks to the 16S ribosomal RNA sequencing technique, recent studies have demonstrated a modification in the diversity and abundance of the microbiota in patients with CRS compared to healthy subjects, notably with a modification of the germs of the firmicutes group. . Few studies have studied the modification of the microbiota with the treatment of CRS today. However, local treatments based on nosewashing with physiological saline associated with local corticosteroids and endoscopic treatments lead to an improvement in the symptomatology for patients suffering from CRS. This study will describe the modification of endonasal microbiota in différent conditions, such medical and surgical treatments, that usually improve patients symptomatology.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04418622
Study type	Observational
Source	University Hospital, Brest
Contact
Status	Completed
Phase
Start date	October 21, 2020
Completion date	November 15, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02266810` - Safety and Efficacy of the Propel Mini and Propel Nova Steroid-Eluting Sinus Implant in Frontal Sinus	Phase 3
Completed	`NCT01706484` - Efficacy and Safety of Two Dosages of a Herbal Medicinal Product (Dry Extract BNO 1016) in Chronic Rhinosinusitis	Phase 3
Completed	`NCT01197612` - Nasal Packing as a Drug Delivery System Postoperatively in Chronic Sinusitis With Polyposis	Phase 3
Completed	`NCT04163978` - Nitric Oxide Releasing Sinus Irrigation (NOSi) to Treat Recalcitrant Chronic Rhinosinusitis (RCRS)	Phase 2
Not yet recruiting	`NCT06070311` - Wound Healing After Endoscopic Sinus Surgery	N/A
Not yet recruiting	`NCT05454163` - Post-radiotherapy Rhinosinusitis in Children
Withdrawn	`NCT01185808` - Vitamin D Supplementation in Chronic Rhinosinusitis With Nasal Polyps	N/A
Completed	`NCT01700725` - Gulf War Illness Nasal Irrigation Study	Phase 2
Withdrawn	`NCT00671281` - The Effect of Tranexamic Acid on Intraoperative and Post-Operative Bleeding in Functional Endoscopic Sinus Surgery	N/A
Completed	`NCT00447837` - Evaluating SPRC-AB01 in Post-Surgical Subjects With Chronic Sinusitis	Phase 2
Recruiting	`NCT04362501` - Efficacy of Dupilumab for Patients With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)	Phase 2
Completed	`NCT05035654` - LYR-220 for Adult Subjects With Chronic Rhinosinusitis (BEACON Study)	Phase 2
Completed	`NCT02562924` - The Efficacy of MEDIHONEY® for Chronic Rhinosinusitis With Nasal Polyposis After Functional Endoscopic Sinus Surgery	N/A
Completed	`NCT01007799` - Vitamin D for Chronic Sinusitis	N/A
Completed	`NCT03358329` - Safety Evaluation of Repeat Placement of the S8 Sinus Implant in Chronic Sinusitis Patients With Nasal Polyps (ENCORE)	Phase 3
Withdrawn	`NCT02981017` - Improvement of Outcomes in Draf III/Endoscopic Modified Lothrop Procedure	N/A
Completed	`NCT04041609` - LYR-210 Depot (LYR-210) for Adult Subjects With Chronic Sinusitis (LANTERN Study)	Phase 2
Recruiting	`NCT01854619` - Photodynamic Therapy for the Treatment of Chronic Rhinosinusitis	N/A
Completed	`NCT00924404` - Xylitol Versus Saline in Chronic Sinusitis	N/A
Not yet recruiting	`NCT03903432` - The Feasibility of Using MRI During ESS	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Evolution of the Endonasal Microbiota in Patients With Chronic Rhinosinusitis — METEL-RC

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms